Naomi Aoki | VP, Corporate Communications & IR |
Nancy Simonian | President, CEO & Director |
Joseph Ferra | CFO |
David Roth | Chief Medical Officer |
Philip Nadeau | Cowen and Company |
Zegbeh Jallah | Roth Capital Partners |
Good morning, and welcome to Syros Pharmaceuticals' First Quarter 2020 Financial Results Conference Call. [Operator Instructions].
At this time, I would like to turn the call over to Naomi Aoki, Vice President of Corporate Communications and Investor Relations at Syros.
Thank you. This morning, we issued a press release with our first quarter 2020 financial results, along with anticipated future milestones and recent accomplishments.